Key features and details
- Rabbit polyclonal to Ataxin 1
- Suitable for: IHC-P
- Reacts with: Human
- Isotype: IgG
Product nameAnti-Ataxin 1 antibody
See all Ataxin 1 primary antibodies
DescriptionRabbit polyclonal to Ataxin 1
Tested applicationsSuitable for: IHC-Pmore details
Species reactivityReacts with: Human
Predicted to work with: Mouse, Rat
Recombinant fragment corresponding to Human Ataxin 1 aa 586-815.
ELKKVEDLKTEDFIQSAEISNDLKIDSSTVERIEDSHSPGVAVIQFAVGE HRAQVSVEVLVEYPFFVFGQGWSSCCPERTSQLFDLPCSKLSVGDVCISL TLKNLKNGSVKKGQPVDPASVLLKHSKADGLAGSRHRYAEQENGINQGSA QMLSENGELKFPEKMGLPAAPFLTKIEPSKPAATRKRRWSAPESRKLEKS EDEPPLTLPKPSLIPQEVKICIEGRSNVGK
Database link: P54253
- IHC-P: Human gallbladder tissue.
Storage instructionsShipped at 4°C. Store at +4°C short term (1-2 weeks). Upon delivery aliquot. Store at -20°C long term. Avoid freeze / thaw cycle.
Storage bufferpH: 7.30
Preservative: 0.02% Sodium azide
Constituents: 50% Glycerol (glycerin, glycerine), PBS
Concentration information loading...
PurityImmunogen affinity purified
Our Abpromise guarantee covers the use of ab238105 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
|IHC-P||1/20 - 1/200.|
FunctionBinds RNA in vitro. May be involved in RNA metabolism. The expansion of the polyglutamine tract may alter this function.
Tissue specificityWidely expressed throughout the body.
Involvement in diseaseDefects in ATXN1 are the cause of spinocerebellar ataxia type 1 (SCA1) [MIM:164400]; also known as olivopontocerebellar atrophy I (OPCA I or OPCA1). Spinocerebellar ataxia is a clinically and genetically heterogeneous group of cerebellar disorders. Patients show progressive incoordination of gait and often poor coordination of hands, speech and eye movements, due to cerebellum degeneration with variable involvement of the brainstem and spinal cord. SCA1 belongs to the autosomal dominant cerebellar ataxias type I (ADCA I) which are characterized by cerebellar ataxia in combination with additional clinical features like optic atrophy, ophthalmoplegia, bulbar and extrapyramidal signs, peripheral neuropathy and dementia. SCA1 is caused by expansion of a CAG repeat in the coding region of ATXN1. Longer expansions result in earlier onset and more severe clinical manifestations of the disease.
Sequence similaritiesBelongs to the ATXN1 family.
Contains 1 AXH domain.
DomainThe AXH domain is required for interaction with CIC.
modificationsPhosphorylation at Ser-775 increases the pathogenicity of proteins with an expanded polyglutamine tract.
Sumoylation is dependent on nuclear localization and phosphorylation at Ser-775. It is reduced in the presence of an expanded polyglutamine tract.
Cellular localizationCytoplasm. Nucleus. Colocalizes with USP7 in the nucleus.
- Information by UniProt
- alternative ataxin1 antibody
- Ataxin-1 antibody
- ATX1 antibody
To our knowledge, customised protocols are not required for this product. Please try the standard protocols listed below and let us know how you get on.
ab238105 has not yet been referenced specifically in any publications.